Related references
Note: Only part of the references are listed.MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential
Erica Ballabio et al.
BLOOD (2010)
Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas
Eri Hiroki et al.
CANCER SCIENCE (2010)
Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial
Maria-Victoria Mateos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling
N. C. Gutierrez et al.
LEUKEMIA (2010)
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma
Olaf Merkel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification
Basile Stamatopoulos et al.
BLOOD (2009)
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
Marta Lionetti et al.
BLOOD (2009)
Patterns of microRNA expression characterize stages of human B-cell differentiation
Jenny Zhang et al.
BLOOD (2009)
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren et al.
BLOOD (2009)
Aberrant expression of microRNA biosynthetic pathway components is a common feature of haematological malignancy
Charles H. Lawrie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
MicroRNA expression in chronic lymphocytic leukaemia
Charles H. Lawrie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
MicroRNA 223-dependent expession of LMO2 regulates normal erythropoiesis
Nadia Felli et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma
Charles H. Lawrie et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R. Fonseca et al.
LEUKEMIA (2009)
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
Charles H. Lawrie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1
Queenie W. -L. Wong et al.
GASTROENTEROLOGY (2008)
microRNA expression in lymphoid malignancies: new hope for diagnosis and therapy?
Charles Henderson Lawrie
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
MicroRNA expression in lymphocyte development and malignancy
C. H. Lawrie et al.
LEUKEMIA (2008)
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Qihong Huang et al.
NATURE CELL BIOLOGY (2008)
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Flavia Pichiorri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc
Baltazar D. Aguda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition
Nicole Cloonan et al.
GENOME BIOLOGY (2008)
Downregulation of microRNAs-143 and-145 in B-cell malignancies
Yukihiro Akao et al.
CANCER SCIENCE (2007)
Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein
Francesco Fazi et al.
CANCER CELL (2007)
MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma
Charles H. Lawrie et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
MicroRNAs and haematology: small molecules, big function
Charles H. Lawrie
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas
Yasodha Natkunam et al.
BLOOD (2007)
Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA
Anwar Hossain et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Prevalence of monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
GA Calin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma
FM Ross et al.
LEUKEMIA (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival
S Wuillème-Toumi et al.
LEUKEMIA (2005)
A microRNA polycistron as a potential human oncogene
L He et al.
NATURE (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
International staging system for multiple myeloma
PR Greipp et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma
S Wuilleme et al.
LEUKEMIA (2005)
Normalization of cDNA microarray data
GK Smyth et al.
METHODS (2003)
Review of 1027 patients with newly diagnosed multiple myeloma
RA Kyle et al.
MAYO CLINIC PROCEEDINGS (2003)
MicroRNA maturation: stepwise processing and subcellular localization
Y Lee et al.
EMBO JOURNAL (2002)
Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria
B Sirohi et al.
BONE MARROW TRANSPLANTATION (2001)
Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy
R Fonseca et al.
LEUKEMIA (2001)
Share Paper
